Genomics

Dataset Information

0

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients


ABSTRACT: Alterations in the genetic content, such as Copy Number Variations (CNVs) is one of the hallmarks of cancer and their detection is used to recognize tumoral DNA. Analysis of cell-free DNA from plasma is a powerful tool for non-invasive disease monitoring in cancer patients. Here we exploit third generation sequencing (Nanopore) to obtain a CNVs profile of tumoral DNA from plasma, where cancer-related chromosomal alterations are readily identifiable. Compared to Illumina sequencing -the only available alternative- Nanopore sequencing represents a viable approach to characterize the molecular phenotype, both for its ease of use, costs and rapid turnaround (6 hours).

PROVIDER: EGAS00001004975 | EGA |

REPOSITORIES: EGA

Similar Datasets

| 2094858 | ecrin-mdr-crc
2018-09-11 | GSE119764 | GEO
2010-06-11 | E-GEOD-19469 | biostudies-arrayexpress
2019-10-24 | GSE136962 | GEO
2012-06-30 | E-GEOD-30542 | biostudies-arrayexpress
2014-01-01 | GSE42769 | GEO
2010-06-11 | GSE19469 | GEO
2011-12-31 | GSE30481 | GEO
2012-07-01 | GSE30542 | GEO
2016-12-01 | GSE85010 | GEO